Hemoglobin distribution width

A rapid assessment of dense red cells in the steady state and during painful crisis in sickle cell anemia

Henny H. Billett, M. E. Fabry, R. L. Nagel

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Hemoglobin distribution width (HDW) is a measurement of the heterogeneity of the red cell hemoglobin concentration as determined by the Technicon H1 automatic counter. The utility of this measurement for patients with sickle cell disease was assessed in 275 samples from 61 patients. We found that patients with sickle cell disease in steady state had an elevated HDW (3.89 ± 0.82 gm/dl) compared with the normal range of 2.2 to 3.2 gm/dl, and that this value correlated strongly with the number of dense red cells (r=0.72, p < 1 x 10-10). When HDW was determined daily for patients with SS in painful crisis, the decline in dense cells observed during this event was paralleled by a decrease in HDW. The percent of dense cells fell from steady state levels of 10.0% ± 9.5% to 5.7% ± 4.9% at the beginning (days 1 through 3) to 3.1% ± 2.0% at the end of painful crisis (days 6 through 9). HDW decreased from the steady state value of 3.89 ± 0.82 gm/dl to 3.44 ± 0.73 gm/dl at the beginning of crisis and fell further to 3.14 ± 0.40 gm/dl at the end. We conclude that HDW is a rapid and reliable assessment of the percent of dense cells in sickle cell disease and is a useful objective parameter to follow in sickle cell crisis.

Original languageEnglish (US)
Pages (from-to)339-344
Number of pages6
JournalJournal of Laboratory and Clinical Medicine
Volume112
Issue number3
StatePublished - 1988

Fingerprint

Sickle Cell Anemia
Hemoglobins
Cells
Reference Values

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

@article{3328813a398d4874b4b528b960ce1800,
title = "Hemoglobin distribution width: A rapid assessment of dense red cells in the steady state and during painful crisis in sickle cell anemia",
abstract = "Hemoglobin distribution width (HDW) is a measurement of the heterogeneity of the red cell hemoglobin concentration as determined by the Technicon H1 automatic counter. The utility of this measurement for patients with sickle cell disease was assessed in 275 samples from 61 patients. We found that patients with sickle cell disease in steady state had an elevated HDW (3.89 ± 0.82 gm/dl) compared with the normal range of 2.2 to 3.2 gm/dl, and that this value correlated strongly with the number of dense red cells (r=0.72, p < 1 x 10-10). When HDW was determined daily for patients with SS in painful crisis, the decline in dense cells observed during this event was paralleled by a decrease in HDW. The percent of dense cells fell from steady state levels of 10.0{\%} ± 9.5{\%} to 5.7{\%} ± 4.9{\%} at the beginning (days 1 through 3) to 3.1{\%} ± 2.0{\%} at the end of painful crisis (days 6 through 9). HDW decreased from the steady state value of 3.89 ± 0.82 gm/dl to 3.44 ± 0.73 gm/dl at the beginning of crisis and fell further to 3.14 ± 0.40 gm/dl at the end. We conclude that HDW is a rapid and reliable assessment of the percent of dense cells in sickle cell disease and is a useful objective parameter to follow in sickle cell crisis.",
author = "Billett, {Henny H.} and Fabry, {M. E.} and Nagel, {R. L.}",
year = "1988",
language = "English (US)",
volume = "112",
pages = "339--344",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Hemoglobin distribution width

T2 - A rapid assessment of dense red cells in the steady state and during painful crisis in sickle cell anemia

AU - Billett, Henny H.

AU - Fabry, M. E.

AU - Nagel, R. L.

PY - 1988

Y1 - 1988

N2 - Hemoglobin distribution width (HDW) is a measurement of the heterogeneity of the red cell hemoglobin concentration as determined by the Technicon H1 automatic counter. The utility of this measurement for patients with sickle cell disease was assessed in 275 samples from 61 patients. We found that patients with sickle cell disease in steady state had an elevated HDW (3.89 ± 0.82 gm/dl) compared with the normal range of 2.2 to 3.2 gm/dl, and that this value correlated strongly with the number of dense red cells (r=0.72, p < 1 x 10-10). When HDW was determined daily for patients with SS in painful crisis, the decline in dense cells observed during this event was paralleled by a decrease in HDW. The percent of dense cells fell from steady state levels of 10.0% ± 9.5% to 5.7% ± 4.9% at the beginning (days 1 through 3) to 3.1% ± 2.0% at the end of painful crisis (days 6 through 9). HDW decreased from the steady state value of 3.89 ± 0.82 gm/dl to 3.44 ± 0.73 gm/dl at the beginning of crisis and fell further to 3.14 ± 0.40 gm/dl at the end. We conclude that HDW is a rapid and reliable assessment of the percent of dense cells in sickle cell disease and is a useful objective parameter to follow in sickle cell crisis.

AB - Hemoglobin distribution width (HDW) is a measurement of the heterogeneity of the red cell hemoglobin concentration as determined by the Technicon H1 automatic counter. The utility of this measurement for patients with sickle cell disease was assessed in 275 samples from 61 patients. We found that patients with sickle cell disease in steady state had an elevated HDW (3.89 ± 0.82 gm/dl) compared with the normal range of 2.2 to 3.2 gm/dl, and that this value correlated strongly with the number of dense red cells (r=0.72, p < 1 x 10-10). When HDW was determined daily for patients with SS in painful crisis, the decline in dense cells observed during this event was paralleled by a decrease in HDW. The percent of dense cells fell from steady state levels of 10.0% ± 9.5% to 5.7% ± 4.9% at the beginning (days 1 through 3) to 3.1% ± 2.0% at the end of painful crisis (days 6 through 9). HDW decreased from the steady state value of 3.89 ± 0.82 gm/dl to 3.44 ± 0.73 gm/dl at the beginning of crisis and fell further to 3.14 ± 0.40 gm/dl at the end. We conclude that HDW is a rapid and reliable assessment of the percent of dense cells in sickle cell disease and is a useful objective parameter to follow in sickle cell crisis.

UR - http://www.scopus.com/inward/record.url?scp=0023778303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023778303&partnerID=8YFLogxK

M3 - Article

VL - 112

SP - 339

EP - 344

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 3

ER -